Action on anaphylaxis action plans

Abstract

The provision of a written anaphylaxis action plan is considered to be an essential component of the management of food-allergic children prescribed self-injectable adrenaline. Literature review indicates that the evidence that such plans are of benefit is incomplete; however, commonsense would suggest that this is the case. Controlled trials are unlikely to be performed. The Australasian Society of Clinical Immunology and Allergy has recently released three anaphylaxis action plans that meet the differing needs of those children prescribed self-injectable adrenaline, those who do not warrant self-injectable adrenaline provision and those with insect allergy.